Daniel Buckelew is currently the Associate Director of Dupixent Forecasting in Dermatology at Sanofi, where they have been since 2025. With a progressive background in Global 500 and Fortune 500 companies, Daniel has developed expertise in finance, client relations, and project management. They previously served as a Financial Analyst at Dey Pharma L.P and held various finance management roles at Sanofi Genzyme. Daniel earned both a Bachelor of Science in Business Management and an MBA in Finance from Centenary University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices